G01N 2469/20
Detection of antibodies in sample from host which are directed against antigens
Official title: Detection of antibodies in sample from host which are directed against antigens from microorganisms
G01N2469/20 (Detection of antibodies in sample from host which are directed against antigens) appears on 834 US grants and 1,398 published applications in this corpus.
Search patents in G01N- Granted patents
- 834
- Published applications
- 1,398
- Assignees
- 735
- Inventors
- 2,830
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 4 | 0 |
| 1992 | 3 | 0 |
| 1993 | 2 | 0 |
| 1994 | 3 | 0 |
| 1995 | 0 | 0 |
| 1996 | 4 | 0 |
| 1997 | 5 | 0 |
| 1998 | 7 | 0 |
| 1999 | 20 | 0 |
| 2000 | 16 | 0 |
| 2001 | 13 | 3 |
| 2002 | 14 | 22 |
| 2003 | 17 | 33 |
| 2004 | 13 | 34 |
| 2005 | 17 | 45 |
| 2006 | 17 | 42 |
| 2007 | 26 | 40 |
| 2008 | 26 | 28 |
| 2009 | 13 | 40 |
| 2010 | 28 | 61 |
| 2011 | 30 | 47 |
| 2012 | 35 | 44 |
| 2013 | 30 | 49 |
| 2014 | 32 | 47 |
| 2015 | 32 | 77 |
| 2016 | 46 | 73 |
| 2017 | 46 | 60 |
| 2018 | 57 | 56 |
| 2019 | 59 | 50 |
| 2020 | 35 | 47 |
| 2021 | 36 | 76 |
| 2022 | 29 | 82 |
| 2023 | 26 | 135 |
| 2024 | 33 | 89 |
| 2025 | 33 | 83 |
| 2026 | 26 | 35 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Bovine pathogen array29 Sep 2026US 12,748,110 B2Randox Laboratories Limited
- Antigen for 2019 novel Coronavirus and detection use thereof15 Sep 2026US 12,736,543 B2Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
- Cartridge-based automated rapid test analyzer8 Sep 2026US 12,730,069 B2Genesis Intelligence, LLC
- Methods for modulation of coronavirus infection1 Sep 2026US 12,724,031 B2Laboratory Corporation of America Holdings
- Automated pathogen and antibody rapid test25 Aug 2026US 12,716,891 B2Gensis Intelligence, LLC
- Compositions and methods for detection and treatment of coccidioides infection8 Oct 2026US 2026/0309707 A1The Translational Genomics Research Institute
- Ace2 inhibition assay for evaluation of vaccine immunogenicity8 Oct 2026US 2026/0309709 A1Novavax, Inc.
- Methods for detecting rocahepevirus1 Oct 2026US 2026/0298928 A1Abbott Laboratories
- Compositions and methods for preventing, controlling and diagnosing mycobacterial infections17 Sep 2026US 2026/0273038 A1University of Saskatchewan
- Rsv vaccine composition, method and use thereof10 Sep 2026US 2026/0263581 A1Sichuan Clover Biopharmaceuticals, Inc.
Most cited
By later US patents
- Method and system for preventing virus-related obesity and obesity related diseases86US 8,585,588 B2NoHands, LLC · 2013
- Circovirus sequences associated with piglet weight loss disease (PWD)84US 6,703,023 B1Agence Francaise De Securite Sanitaire Des Aliments · 2004
- Baculovirus expression vectors and recombinant antigens for detecting type-specific antibodies to herpes simplex virus80US 6,013,433 AThe United States of America, as represented by the Secretary, Department of Health and Human Services · 2000
- Baculovirus expression vectors and recombinant antigens for detecting type-specific antibodies to herpes simplex virus78US 6,126,944 AThe United States of America as represented by the Department of Health and Human Services · 2000
- Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents70US 5,885,823 ANOBL Laboratories, Inc. · 1999